Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J HIRSH

Showing results (551-560 of 666) with videos related to

Pageof 67
Sort By:
Blood|September 15, 1992
Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cellsL Rosenfeld, A Kuo, J Hirsh, et al.
Journal of Thrombosis and Haemostasis : JTH|April 12, 2007
Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgeryD J Quinlan, J W Eikelboom, O E Dahl, et al.
Chest|April 1, 1990
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trialA G Turpie, M N Levine, J Hirsh, et al.
Chest|February 7, 2001
Managing oral anticoagulant therapyJ Ansell, J Hirsh, J Dalen, et al.
Biochemistry|August 19, 2007
Adenosine deaminase 1 and concentrative nucleoside transporters 2 and 3 regulate adenosine on the apical surface of human airway epithelia: implications for inflammatory lung diseasesAndrew J Hirsh, Jaclyn R Stonebraker, Catja A van Heusden, et al.
Thrombosis Research|September 15, 1984
A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparationJ F Cade, M R Buchanan, B Boneu, et al.
Chest|November 20, 1998
Platelet-active drugs: the relationships among dose, effectiveness, and side effectsC Patrono, B Coller, J E Dalen, et al.
Molecular Cell|August 21, 2001
The CF salt controversy: in vivo observations and therapeutic approachesR Tarran, B R Grubb, D Parsons, et al.
Chest|February 7, 2001
Platelet-active drugs : the relationships among dose, effectiveness, and side effectsC Patrono, B Coller, J E Dalen, et al.
Circulation|April 1, 1976
Heparin kinetics in venous thrombosis and pulmonary embolismJ Hirsh, W G van Aken, A S Gallus, et al.
Pageof 67

Showing results (551-560 of 666) with videos related to

Sort By:
Pageof 67
Blood|September 15, 1992
Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cellsL Rosenfeld, A Kuo, J Hirsh, et al.
Journal of Thrombosis and Haemostasis : JTH|April 12, 2007
Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgeryD J Quinlan, J W Eikelboom, O E Dahl, et al.
Chest|April 1, 1990
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trialA G Turpie, M N Levine, J Hirsh, et al.
Chest|February 7, 2001
Managing oral anticoagulant therapyJ Ansell, J Hirsh, J Dalen, et al.
Biochemistry|August 19, 2007
Adenosine deaminase 1 and concentrative nucleoside transporters 2 and 3 regulate adenosine on the apical surface of human airway epithelia: implications for inflammatory lung diseasesAndrew J Hirsh, Jaclyn R Stonebraker, Catja A van Heusden, et al.
Thrombosis Research|September 15, 1984
A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparationJ F Cade, M R Buchanan, B Boneu, et al.
Chest|November 20, 1998
Platelet-active drugs: the relationships among dose, effectiveness, and side effectsC Patrono, B Coller, J E Dalen, et al.
Molecular Cell|August 21, 2001
The CF salt controversy: in vivo observations and therapeutic approachesR Tarran, B R Grubb, D Parsons, et al.
Chest|February 7, 2001
Platelet-active drugs : the relationships among dose, effectiveness, and side effectsC Patrono, B Coller, J E Dalen, et al.
Circulation|April 1, 1976
Heparin kinetics in venous thrombosis and pulmonary embolismJ Hirsh, W G van Aken, A S Gallus, et al.
Pageof 67